Could Cell Therapy Target the Symptoms of Severe Covid-19?

The excessive inflammatory response seen in the most serious cases of Covid-19, along with shortages of ventilators, has caused a healthcare crisis in many countries around the world. Could cell therapy provide an answer...

Sleep-wake disturbances can predict recurrent events in stroke survivors

Credit: EAN (Vienna, Sunday, 24 May, 2020) Stroke survivors suffering from the burden of combined sleep-wake disturbances are more likely to have another stroke or serious cardio-...

First COVID-19 vaccine found to be safe, able to generate rapid immune response in...

Reviewed by Emily Henderson, B.Sc.May 22 2020 The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans,...

Cost-effective canopy protects health workers from COVID infection during ventilation

Credit: Photo courtesy of Prof. Yochai Adir. Researchers have designed a cost-effective, constant flow plastic canopy system that can help to protect healthcare workers who are at...

UK Biotech’s US Antibody Patents Upheld in Regeneron Battle

UK biotech Kymab has won the latest skirmish in its ongoing legal battle with the US giant Regeneron regarding patents protecting their rival antibody-producing technologies. The outcome of the battle could have big implications...

Polycistronic delivery of IL-10 and NT-3 to enhance spinal cord injury repair

Reviewed by Emily Henderson, B.Sc.Apr 18 2020 Spinal cord injury (SCI) creates a complex microenvironment that is not conducive to repair; growth factors are in short supply, whereas factors that inhibit regeneration are plentiful. In...

Creso Pharma’s Technological Breakthrough Set To Expand Human Health Cannabis Product Line

By BioChannel -   February 10th 2020  566  By Jonathan Jackson Creso Pharma Limited (ASX:CPH), the ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as...

Perth Biotech Increases Sanitiser Shipment Amid Virus Outbreak

Merlin Chew of The West Australian Monday, 10 February 2020 2:30PM Holista Colltech chief executive Dr Rajen M with the NatShield Sanitizer. Credit: Supplied

Zoono at Cutting Edge of Reducing Risk of African Swine Flu Outbreaks

Paul Hislop, CEO and majority shareholder of ASX listed ZOONO Group Ltd (ZNO) confirmed at their AGM held in Sydney on 7th November 2109 that Zoono was at that cutting edge of...

Stay connected

47,340FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article